Company Comparison
Blueprint Medicines vs 23andMe
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Blueprint Medicines | 23andMe |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Cambridge, MA | South San Francisco, California |
| Founded | 2011 | 2006 |
| Status | Active | Active |
| Last Funding Stage | IPO | — |
| Total Funding | $676M | — |
| Valuation | — | — |
What They Build
Blueprint Medicines
Precision medicine company developing targeted therapies for cancer and rare diseases using genomics-based drug discovery.
23andMe
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California.
Key Investors
Blueprint Medicines
Sector Overlap
Both Blueprint Medicines and 23andMe operate in Biotech.
Browse all Biotech companies →